Propolis and gastrointestinal tract diseases
dc.authorscopusid | 57222637358 | |
dc.authorscopusid | 55628003500 | |
dc.authorscopusid | 23666338900 | |
dc.contributor.author | Gültekin Subaşı,B. | |
dc.contributor.author | Ozdal,T. | |
dc.contributor.author | Capanoglu,E. | |
dc.date.accessioned | 2024-05-25T12:18:15Z | |
dc.date.available | 2024-05-25T12:18:15Z | |
dc.date.issued | 2022 | |
dc.department | Okan University | en_US |
dc.department-temp | Gültekin Subaşı B., Department of Food Engineering, Istanbul Technical University, Istanbul, Maslak, Turkey, Hafik Kamer Ornek Vocational School, Sivas Cumhuriyet University, Sivas, Turkey; Ozdal T., Department of Food Engineering, Istanbul Okan University, Istanbul, Tuzla, Turkey; Capanoglu E., Department of Food Engineering, Istanbul Technical University, Istanbul, Maslak, Turkey | en_US |
dc.description.abstract | Propolis, the resinous “bee glue,” has been investigated widely due to its bioactive phytochemicals and potential to treat various diseases. Gastrointestinal tract disorders are among the severe diseases that many individuals suffer as either recoverable in specific periods or for life-long situations. From the loss of daily-life quality to life-threatening severe cases, gastrointestinal tract disorders have a wide range of symptoms usually palliated by medication; however, those rarely target to cure the origin of a disease or reverse the pathologic lesions. Symptom palliation and/or suppression might cause many other undesired side effects which may require different medication. Propolis has a significant potential to treat these challenging diseases instead of suppressing the symptoms. The present chapter covers the potential effects of propolis bioactive compounds and phytochemicals with their brief mechanism of action on oral mucositis, gastrointestinal cancers, inflammatory bowel disease, and antiulcer activity. © 2022 Elsevier Inc. All rights reserved. | en_US |
dc.identifier.citation | 0 | |
dc.identifier.doi | 10.1016/B978-0-323-85400-9.00013-7 | |
dc.identifier.endpage | 158 | en_US |
dc.identifier.isbn | 978-032385400-9 | |
dc.identifier.isbn | 978-032390074-4 | |
dc.identifier.scopus | 2-s2.0-85139606871 | |
dc.identifier.startpage | 139 | en_US |
dc.identifier.uri | https://doi.org/10.1016/B978-0-323-85400-9.00013-7 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14517/1676 | |
dc.language.iso | en | |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Bee Products and Their Applications in the Food and Pharmaceutical Industries | en_US |
dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Duodenal ulcer | en_US |
dc.subject | Gastric ulcer | en_US |
dc.subject | Gastrointestinal cancer | en_US |
dc.subject | Inflammatory bowel disease | en_US |
dc.subject | Oral mucositis | en_US |
dc.subject | Peptic ulcer | en_US |
dc.subject | Phytochemicals | en_US |
dc.subject | Propolis | en_US |
dc.title | Propolis and gastrointestinal tract diseases | en_US |
dc.type | Book Part | en_US |
dspace.entity.type | Publication |